biotech · Blepharitis · Meibomian Gland Dysfunction · TARS
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a biotech organization headquartered in Irvine, USA. It trades on NYSE under ticker TARS. Primary therapeutic focus areas include Blepharitis, Meibomian Gland Dysfunction, Papulopustular Rosacea
15440 Laguna Canyon Rd, Irvine, California 92618, US HQ
2017 Founded
403 Employees
Public company Type
TARS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 15440 Laguna Canyon Rd, Irvine, California 92618, US
- Founded
- 2017
- Employees
- 403
- Programs
- 14
- Drugs
- 10
- Patents
- 9
Standart medical treatment
Unknown · small molecule · High Intensity Interval Training
Standart medical treatment for High Intensity Interval Training is a Unknown program (small_molecule) at Tarsus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code 2024/17
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Tarsus Pharmaceuticals
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- High Intensity Interval Training
- Status
- active
- Trials
- 1